| 1 |
Kaladhar DS, Srinivasan T. Comparative genomics and molecular epidemiology on hepatitis virus–induced hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma 2022. [DOI: 10.1016/b978-0-323-98806-3.00005-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Philips CA, Ahamed R, Abduljaleel JK, Rajesh S, Augustine P. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021;13:e19152. [PMID: 34733599 DOI: 10.7759/cureus.19152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Rammohan A. Current management & future directions in post-liver transplant recurrence of viral hepatitis. Journal of Liver Transplantation 2021;3:100027. [DOI: 10.1016/j.liver.2021.100027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Asadi-Asadabad S, Sarvnaz H, Amiri MM, Mobini M, Khoshnoodi J, Hojjat-Farsangi M, Jeddi-Tehrani M, Golsaz-Shirazi F, Shokri F. Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection. Viral Immunol 2021. [PMID: 34030480 DOI: 10.1089/vim.2021.0040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Golsaz-Shirazi F, Shokri F. Cross talk between hepatitis B virus and innate immunity of hepatocytes. Rev Med Virol 2021;:e2256. [PMID: 34021666 DOI: 10.1002/rmv.2256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Golsaz-Shirazi F, Asadi-Asadabad S, Sarvnaz H, Mehdi Amiri M, Hojjat-Farsangi M, Chudy M, Jeddi-Tehrani M, Shokri F. Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes. Clin Chim Acta 2020;510:203-10. [PMID: 32679130 DOI: 10.1016/j.cca.2020.07.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 7 |
Golsaz-Shirazi F, Amiri MM, Shokri F. Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection. Rev Med Virol 2018;28:e2007. [PMID: 30175481 DOI: 10.1002/rmv.2007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 8 |
Burwitz BJ, Wettengel JM, Mück-Häusl MA, Ringelhan M, Ko C, Festag MM, Hammond KB, Northrup M, Bimber BN, Jacob T, Reed JS, Norris R, Park B, Moller-Tank S, Esser K, Greene JM, Wu HL, Abdulhaqq S, Webb G, Sutton WF, Klug A, Swanson T, Legasse AW, Vu TQ, Asokan A, Haigwood NL, Protzer U, Sacha JB. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques. Nat Commun 2017;8:2146. [PMID: 29247188 DOI: 10.1038/s41467-017-01953-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 9 |
Li N, Shi Y, Zhang P, Sang J, Li F, Deng H, Lv Y, Han Q, Liu Z. Association of the tandem polymorphisms (rs148314165, rs200820567) in TNFAIP3 with chronic hepatitis B virus infection in Chinese Han population. Virol J 2017;14:148. [PMID: 28784141 DOI: 10.1186/s12985-017-0814-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 10 |
Golsaz-shirazi F, Amiri MM, Farid S, Bahadori M, Bohne F, Altstetter S, Wolff L, Kazemi T, Khoshnoodi J, Hojjat-farsangi M, Chudy M, Jeddi-tehrani M, Protzer U, Shokri F. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research 2017;144:153-63. [DOI: 10.1016/j.antiviral.2017.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 11 |
Li S, Xie M, Li W, Peng Q, Zhong B, Lu X, Ma Q. Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China. Arch Virol 2017;162:2949-57. [DOI: 10.1007/s00705-017-3437-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 12 |
Golsaz-Shirazi F, Mohammadi H, Amiri MM, Khoshnoodi J, Kardar GA, Jeddi-Tehrani M, Shokri F. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies. Arch Virol 2016;161:2765-72. [PMID: 27439498 DOI: 10.1007/s00705-016-2980-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 13 |
Wu SS, Tang YY, Wang JL, Chen XH, Zhang Y, Tang ZH, Zang GQ, Yu YS. Mechanism for cytoplasmic transduction peptide-HBcAg18-27-Tapasin to induce HBV specific CTL response in C57BL/6 mice. Shijie Huaren Xiaohua Zazhi 2016; 24(17): 2688-2695 [DOI: 10.11569/wcjd.v24.i17.2688] [Reference Citation Analysis]
|
